| Literature DB >> 31221969 |
Xiaoyu Chen1, Rui Li1, Siu Hong Dexter Wong1, Kongchang Wei2, Miao Cui3, Huaijun Chen4, Yuanzhang Jiang5, Boguang Yang1, Pengchao Zhao1, Jianbin Xu6, Heng Chen7, Chao Yin1, Sien Lin8,9, Wayne Yuk-Wai Lee8,9, Yihan Jing1, Zhen Li4, Zhengmeng Yang8,9, Jiang Xia10, Guosong Chen4, Gang Li8,9, Liming Bian11,12,13,14.
Abstract
Folded single chain polymeric nano-objects are the molecular level soft material with ultra-small size. Here, we report an easy and scalable method for preparing single-chain nanogels (SCNGs) with improved efficiency. We further investigate the impact of the dynamic molecular conformational change of SCNGs on cellular interactions from molecular to bulk scale. First, the supramolecular unfoldable SCNGs efficiently deliver siRNAs into stem cells as a molecular drug carrier in a conformation-dependent manner. Furthermore, the conformation changes of SCNGs enable dynamic and precise manipulation of ligand tether structure on 2D biomaterial interfaces to regulate the ligand-receptor ligation and mechanosensing of cells. Lastly, the dynamic SCNGs as the building blocks provide effective energy dissipation to bulk biomaterials such as hydrogels, thereby protecting the encapsulated stem cells from deleterious mechanical shocks in 3D matrix. Such a bottom-up molecular tailoring strategy will inspire further applications of single-chain nano-objects in the biomedical area.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31221969 PMCID: PMC6586678 DOI: 10.1038/s41467-019-10640-z
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919
Fig. 1Preparation and characterization of the supramolecular SCNGs at high concentrations. a, b The preparation scheme of the c unfoldable dynamic ADA@CD-SCNGs, d unfolding process of the ADA@CD-SCNGs, e non-unfoldable SCNGs and f non-foldable linear polymer. g GPC traces for the ADA@CD crosslinked unfoldable ADA@CD-SCNGs (green line) and the corresponding unfolded species (orange line) after treating the SCNGs with free competitive ADA. The unfolding of the ADA@CD-SCNGs led to a slight increase in the apparent molecular weight. h DLS analysis of the folded (green line) and unfolded ADA@CD-SCNGs (orange line). i Atomic force microscopy (AFM) height analysis of two-folded ADA@CD-SCNG particles A and B shown in panel j. j AFM height image of the ADA@CD-SCNGs and l the unfolded species. k 3D modelling image of the ADA@CD-SCNGs and m the unfolded species on silica. The length scale bars of j and l are 300.0 nm, of k and m are 100.0 nm. The height colour scale of j and k is from 0 to 10 nm by height, the colour scale of l and m is from 0 to 8.1 nm by height
Fig. 2Macro-CTAs containing long wing blocks minimize interchain crosslinking. a The successful scale-up preparation of unfoldable SCNGs mediated by macro-CTA containing long protective wing blocks (green sphere). The growth boundary (purple sphere) of each polymer chain is embedded in the long wing blocks, thereby preventing interchain crosslinking at a high reactant concentration. b The procedure of preparing non-unfoldable SCNGs. c The scheme of preparing a non-foldable linear control polymer (orange sphere). d Illustration of the failed preparation of SCNGs mediated by CTAs with short or no wing blocks. The growth boundaries of the polymer chains easily overlap at high concentration
Fig. 3The conformation-dependent cellular entry of the supramolecular ADA@CD-SCNGs. a The synthesis of FITC-labelled and RGD-conjugated ADA@CD-SCNGs as siRNA carriers (FL-SCNG-RGD-siRNA). Cartoon illustration of the b structure and c conformation-dependent cellular entry of the experimental SCNGs and control unfolded species used in the delivery test. d Confocal microscopy image of the uptake efficiency of the FL-SCNG-RGD-siRNA complex and control SCNGs after 24 h of incubation with hMSCs. The scale bars in upper panel are 100 µm and in lower panel are 50 µm. e Flow cytometry results of SCNG uptake by hMSCs. f Confocal microscopy images of immunofluorescence staining against RUNX 2 after culturing the hMSCs in osteogenic differentiation media supplemented with the various delivery vehicles for 7 days. The scale bars in the magnified panel are 20 µm, in the inserted panel are 100 µm. g Quantitative analysis of the expression level of the osteogenic marker genes RUNX 2, alkaline phosphatase (ALP) and type I collagen (Col 1) for the groups shown in f by using qRT-PCR. FL FITC-labelled, UF unfolded, RGD RGD peptide, siRNA small interfering RNA. Data are means ± s.e.m. (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001 (ANOVA)
Fig. 4The effect of SCNG-based RGD linkers unfolding on the adhesion and spreading of stem cells. a Synthesis and substrate conjugation of dynamic supramolecular ADA@CD-SCNG-RGD through a click reaction. b The folded ADA@CD-SCNGs on a glass substrate can be observed as particle-like structures (white dots) by SEM. The ADA@CD-SCNG-RGD linkers in the folded state provide a short RGD tether length (λ) and limited mobility (κ), which favour the formation of mature focal adhesions (FAs) and the spreading of cells on the substrate. c The unfolding of the SCNGs resulted in the disappearance of these white dots, and the unfolding of the ADA@CD-SCNG-RGD linkers led to an increased RGD tether length (λ) and mobility (κ), thereby hampering the formation of FAs and the spreading of cells. The scale bars are 100 nm
Fig. 5Conformational change of the dynamic SCNG regulates the behaviour of stem cells. a Carton illustrations of the conformation of the RGD linker in each group. b Viability staining of living cells by calcein-AM shows that cells spread well on substrates conjugated with the folded ADA@CD-SCNG-RGD and MBA-SCNG-RGD linkers, whereas cells gradually detached and shrank in spreading size due to unfolding of the ADA@CD-SCNG-RGD linkers upon the addition of free ADA molecules. Scale bars are 2000 µm. c Immunostaining of focal adhesion complexes (vinculin) and F-actin assembly, and d immunostaining of Yes-associated protein (YAP) for mechanosensing. Scale bars are 50 µm. e Statistical analysis of cell adherence (the percentage of adherent cells out of total number of seeded cells), spreading area, circularity and nuclear localization of YAP for the groups in a. Data are means ± s.e.m. (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001 (ANOVA)
Fig. 6Construction of dynamic hydrogels for cell protection based on the SCNGs. a Schematic illustration of the fabrication of hydrogels by crosslinking 4-arm PEG with the ADA@CD-SCNGs or b CD-LCPs via a click reaction. c Digital photo of the cell-laden ADA@CD-SCNGs hydrogels subjected to cyclic compression at 0.5 Hz for 3 h without resting. d Rheological monitoring of the in situ gelation of the hydrogels crosslinked by the unfoldable ADA@CD-SCNGs (orange line) or non-foldable linear CD-LCPs (green line). e Stress–strain curve of the fully swollen ADA@CD-SCNG hydrogel with encapsulated cells at 0.5 h (orange line), 1.5 h (yellow line) and 3 h (green line). During the 3 h of continuous cyclic compressive loading and unloading (60% peak strain), the hydrogel maintained an energy dissipation property. The obtained ADA@CD-SCNGs hydrogels exhibit significant energy dissipation due to the reversible conformational changes of the SCNGs crosslinkers. f Stress–strain curve of the fully swollen CD-LCP hydrogel with encapsulated cells at 0.5 h (orange line), 1.5 h (yellow line) and 3 h (green line). The CD-LCP hydrogel showed little energy dissipation during the cyclic compression test. g Confocal microscopy images of live/dead staining by calcein-AM (green) (upper panel) and propidium iodide (red) (PI) (middle panel) and staining against ROS (lower panel) of hMSCs encapsulated in the ADA@CD-SCNG hydrogels and h control CD-LCP hydrogels. Scale bars are 200 µm. i Quantitative data of the viable hMSCs encapsulated in the hydrogels. j Quantitative measurement of the averaged ROS expression intensity in the hydrogels. k The expression of IL1, a key cell distress marker, in the hMSCs obtained by using qRT-PCR. Data are means ± s.e.m. (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001 (ANOVA)